Medgenics' EPO Biopump shows early signs of dose-dependent response
This article was originally published in Clinica
Executive Summary
Response to treatment with Medgenics' Epodure Biopump, which is used to deliver therapeutic proteins, is dose-dependent, a study has suggested.